IoT has facilitated predominant advancements in cancer research in incorporating Artificial intelligence (AI) that enables the human decision makers to achieve better decision. Cervical cancer being a significant cause of mortalities among women across the world. Recently, Least Absolute Shrinkage and Selection Operator (LASSO) classifier has launched in predicting recurrence cancer genes in the cervix. However, the optimal selection of genes or recurrence genes in the prediction becomes a challenging task. Hilbert-Schmidt independence criterion with Diversity based Artificial Fish Swarm (H.S.D.A.F.S.) is phased for gene selection in the recurrence prediction to solve this paradigm. At the initial phase, the recurrence gene expression of lncRNA is collected from Geo Datasets. Secondly, data imputation, accomplished with Mode and Mean Missing method (MMM-DI). Thirdly, feature selection is compassed using H.S.D.A.F.S. In the H.S.D.A.F.S. algorithm, the diversity parameter is added based on the gene value and their risk score of the lncRNAs is computed using Artificial intelligence (AI) technique. Finally, recurrence prediction, an ENSemble Classification Framework (E.N.S.C.F.), is proposed by integrating the Internet of Things (IoT) based recurrent neural networks. The results are then combined via weighted majority voting-the prognostic factor computed with a risk score of nine lncRNA signatures for 300 samples taken from GSE44001. The Chi-Square method has pursued to obtain statistical results. The survival of the patient with recurrence cervical cancer is also portrayed in the proposed model.